Dr. Zakaria MD
@ZakariaMDv3 • 50,408 subscribers
Exploring alternative & integrative cancer protocols | Patient stories, research shares, hope & support | Not medical advice. Ivermectin. Oncologist. 💪💪🌿🌿❤️
Videos
Mammograms are a textbook Big Pharma scam. 🎯 They provably cause the cancer they're meant to be detecting. Cancer treatment = golden cash cow for pharma. More diagnoses = more profit. 💰 They don't want you healthy. They want you paying. Share this with the women you love. 👇
Dr. Zakaria MD42,853 次观看 • 2 个月前
Detox from Spike Proteins: Here's How in Under Two Minutes 1.) Ivermectin - Binds tightly to spike protein. It can prevent the virus from entering the cells, and it can prevent the virus from replicating. 2.) Suramin - Like ivermectin, it prevents spike protein from binding to ACE2 receptors. 3.) NAC - Powerful antioxidant. Reduces the damage that happens after toxicity and has been shown to be able to restore damaged cells back to their normal state. 4.) Catechin and Kurkumin - They have potent anti-inflammatory and antioxidant properties.
Dr. Zakaria MD25,900 次观看 • 2 个月前
Dear followers, I’m pleased to announce that a new shipment of ingredients for the updated Joe Tippens Protocol and Dr. William Makis protocol arrived this morning. This shipment includes Fenbendazole, Ivermectin, Vitamin B17, Mebendazole, FECO, Methylene Blue, Onco Adjunct Pathways 1–4, TUDCA, and Activated Charcoal binder. All components are now available in convenient pill form for precise dosing and are manufactured in the USA, which many customers prefer for quality and consistency. I will continue to offer the complete Joe Tippens Protocol kit, which contains: • 10 Tubes of Ivermectin paste . 200 pills of Berberine. . 200 pills of 444 mg Fenbendazole • 200 pills of 12 mg Ivermectin • 200 pills of 500 mg Mebendazole • 200 pills of Vitamin B17 • 100 pills of Methylene Blue • 200 pills of Activated Charcoal binder • 200 pills of TUDCA • 100 pills of Onco Adjunct Pathways 1, 2, 3, and 4. The full kit is available for $650 as a limited-time offer. If you’re interested in securing a kit, please contact me via text or WhatsApp at +1 (754) 330-5858. My thoughts are with everyone navigating difficult health journeys right now. Wishing you continued strength and hope. Best regards, Dr. Zakaria
Dr. Zakaria MD17,283 次观看 • 1 个月前
Ivermectin and Fenbendazole keep coming up in studies. Not the first story I've heard. Probably not the last. But here's what I've learned – from personal experience and from watching others. The Dosage (Simple Rule) If you're taking the paste – no more than the size of your pinky nail per day. Take it for several days, then take a break for a week. Got something chronic? Get advice first. My Experience I was sick in 2023. Took a small dose. The colour came back to my face in one day. Not a miracle. Just a real response. I've also seen viruses improve fast. People I know – really sick – had good results. The Cat, The Cancer, and The Missed Chance I wish I had tried this with my cat, Sam. He had cancer. The vets had no answers. The dose would have been tiny – less than a milligram, based on weight. But I didn't know then what I know now. Why Was It Stopped? It was used routinely. Until Covid. Then suddenly, availability disappeared. You gotta wonder why. Meanwhile, Ivermectin won a Nobel Prize in 2015. And arthritis and cancer share similar inflammatory pathways – Ivermectin has been shown to help both. Be Smart. Be Careful. I'm not a doctor. I recommend talking to NZDSOS – New Zealand Doctors Speaking Out with Science. A body I trust. Find the studies. Keep the dose small. Talk to people who've had good results. One More Thing The problem? They can't make money on a cheap, generic drug. So they don't study it. So they don't promote it.
Dr. Zakaria MD13,684 次观看 • 2 个月前
🚨 Ivermectin for Cancer: The Important Part Most People Miss Ivermectin is being explored for its potential anti-cancer effects; it can disrupt cancer cell mitochondria, interfere with glucose metabolism, and help reactivate apoptosis (the cell’s natural self-destruct system). But here’s what often gets overlooked: Ivermectin can also place extra demand on your body’s detoxification pathways. Supporting your terrain while using it is essential. Here’s how this person supports their body during use: Liposomal glutathione + NAC for liver and mitochondrial support Binders like activated charcoal and fulvic acid to help with detoxification Cycling protocol: 5 days on, 2 days off As they put it: “Ivermectin may help starve the tumor, but don’t starve your terrain in the process.” This approach combines the potential benefits with practical ways to protect overall health. Follow me for more updates.
Dr. Zakaria MD14,209 次观看 • 2 个月前
🚨 WHY ONCOLOGISTS WON’T RECOMMEND IVERMECTIN? Many people are calling out the obvious conflict of interest: ✅ A large portion of an oncologist’s income comes from selling and administering chemotherapy. ✅ Through the “buy and bill” system, doctors can make an 80-90% profit margin on chemo drugs. ✅ This creates a strong financial incentive to keep patients on expensive conventional treatments. Meanwhile, Ivermectin has been approved for human use since 1987 and appears in over 140 peer-reviewed papers related to cancer. It’s also listed by the WHO as an essential medicine.Yet it continues to be dismissed as “horse dewormer” by the same system that profits heavily from chemotherapy.
Dr. Zakaria MD12,011 次观看 • 2 个月前
🚨 BREAKING: JD Vance just revealed on Joe Rogan that the COVID vaccine made him the sickest he's been in 15 years. Not COVID. The shot. He says he caught COVID five separate times. None of them compared. Then he dropped this: we're not even allowed to talk about vaccine side effects in this country. Rogan followed with the receipts. Pharma companies have paid billions in criminal fines but remain completely exempt from vaccine injury liability. Vance then pointed to Big Pharma political donations. When Rogan asked who they donate to, Vance's answer was immediate. This clip is making the rounds for a reason. Watch it before it disappears. 🔥 Follow Dr. Zakaria MD for more 💪 #breakingnews #jdvance #joerogan #jre #covidvaccine #vaccinesideeffects #bigpharma #pharma #exposed #explore #explorepage
Dr. Zakaria MD10,802 次观看 • 2 个月前
EXPERIENCE WITH IVERMECTIN She shared her experience using ivermectin paste for a parasite cleanse, along with a binder (activated charcoal) mixed with milk thistle. Note: The binder is only taken with ivermectin for a parasite cleanse, not for actual cancer treatment. Although the paste already contains binding agents, those ingredients are included to help maintain the paste’s consistency and make it easier to swallow. They are not the same as taking activated charcoal as a binder. The binders are taken as one pill each. The ivermectin cycle is 5 days on, 5 days off, and then 5 days on again. That constitutes one cycle. The cycle is then repeated every 3–4 months. Quarterly refers to how often this cycle is repeated throughout the year. There is more to the protocol, and guidance is provided throughout the process. Like, share and follow me for more updates.
Dr. Zakaria MD14,970 次观看 • 3 个月前
Ivermectin and Mebendazole in Cancer Patients The Clinical Benefit Ratio Complete Response + Partial Response + Stable Disease / Total Patients (CBR) was 84.4% Overall, it is estimated that annual costs of standard chemotherapies average $111,000 per year. Background: Drug repurposing offers a pathway to identify accessible, low-toxicity cancer therapies. Ivermectin and mebendazole have demonstrated multi-target anti-cancer activity. This paper evaluates real-world patient-reported outcomes, safety, and adherence in a cohort of cancer patients utilizing this combination protocol. Methods: Prospective observational cohort of 197 cancer patients, who were prescribed ivermectin and mebendazole off-label through telemedicine (platform by licensed U.S. healthcare providers) Participants received compounded oral capsules containing 25 mg ivermectin and 250 mg mebendazole. Data were collected via voluntary, standardized digital surveys at baseline and at approximately 6-month follow-up. Of the initial cohort (N = 197), baseline characteristics, including cancer type and disease status, were assessed. A total of 122 participants completed the follow-up survey (61.9% response rate) Results: Mean age of 67 years, (52.3% male, 47.7% female). Cancer types included Prostate 27.9% Breast 18.3% Lung 8.6% Colon 5.1% Urologic 4.6% Pancreatic 3.0% Liver 2.5% Gynaecologic 2.5% Hematologic 2.5% Median duration since initial diagnosis, 1.2 years 37.1% experiencing active disease progression. 6-month follow-up Medication adherence, 86.9% Full initial 90-capsule ivermectin-mebendazole prescription. The Clinical Benefit Ratio Complete Response + Partial Response + Stable Disease / Total Patients (CBR) was 84.4% Notably, 48.4% of cohort, strongest positive outcomes: Regression, 15.6% No current evidence of disease (NED), 32.8% Disease stability, 36.1% Disease progression, 15.6% No significant dose-response association was observed for cancer outcomes (p = 0.91), without a clear dose-response gradient for efficacy. Side effects Mild side effects (primarily gastrointestinal), 25.4% (93.6% of those affected continued treatment through minor dose adjustments) Concurrent conventional therapies Chemotherapy, 27.9% Radiation therapy, 21.3% Surgery, 19.7% Adjunctive interventions such as supplement use, 49.2% Dietary modification, 37.7% Conclusions: In this prospective real-world cohort, the combination of ivermectin and mebendazole was associated with high rates of self-reported clinical benefit, with nearly half of participants reporting tumours regression or no current evidence of disease across a heterogeneous population of cancer patients. These findings provide a compelling clinical signal that these well-tolerated, repurposed agents may offer therapeutic benefit. However, observational design, reliance on self-reported outcomes, and potential for selection bias and uncontrolled confounding, these findings should be interpreted as hypothesis-generating. Urgent prospective, randomized, placebo-controlled clinical trials Validate these observations and further define optimal dosing strategies. Mechanism (pharmacodynamics) Ivermectin and mebendazole are antiparasitic agents, demonstrated highly promising anti-cancer activity. Ivermectin Shown to exert over 14 distinct anti-cancer mechanisms across more than 12 cancer types, inhibiting cancer cell proliferation, metastasis, angiogenesis, mitochondrial function. Has demonstrated excellent safety in cancer patients (including those actively undergoing chemotherapy) Ivermectin and mebendazole selectively target cancer stem cells Mebendazole Microtubule disruption, leading to effective cell cycle arrest Potent induction of apoptosis Significant inhibition of tumour growth Inhibition of angiogenesis Disruption of glucose uptake When used together Target non-overlapping pathways, resulting in synergistic tumour regression, cancer stem cell depletion, and reversal of multidrug resistance in multiple in vitro and in vivo models Biodistribution, ivermectin and mebendazole document excellent tissue penetration
Dr. Zakaria MD10,766 次观看 • 3 个月前
12,000 studies on Ivermectin. ZERO studies looking at Ebola. They know Ebola causes a cytokine storm. They know RNA viruses work on similar pathways. But they haven’t researched it. Interestingly.... other peer reviewed research by Zhang et al shows how Ivermectin targets Cytokine Storms. And Dr. Kylie Wagstaff, author of anti-parasitic drug research said Ivermectin “works on a pathway we have innately inside ourselves, that a lot of viruses try to target”. Dr. John Campbell can’t help but be left disappointed with the World Health Organization (WHO). Cases missed weeks before they declared an emergency.... and no consideration of a “life saving agent”. He knows exactly what he would though.
Dr. Zakaria MD11,637 次观看 • 4 个月前
没有更多内容可加载